New Delhi [India], Oct 13 (ANI
-BusinessWireIndia): With a CAGR of 14 percent, Indian Pharmaceutical Industry will reach an annual turnover of USD 47.06 Billion by 2018.
An industry predominantly focused on Generics is soon set to diversify its product portfolio to more than 500 APIs, 60,000 generics, CRAM and clinical services across the globe.
The sector sees a continuous support from the government as well, with revised amendments in the patent act of 2002, increased expenditure in the healthcare sector as claimed by National Health Policy Draft 2015.
Also, 100 percent FDI allowed in medical device industry through automatic route is encouraging the leading Indian Pharma companies to raise funds in order to acquire more entities in domestic as well as international markets. So much so, that the current advancements are towards Japan's lucrative USD 111 billion market.
Though a tough nut to crack, this shouldn't be impermeable after an established record in the USA and Europe. After all the aim is high - to make this industry realize it's worth of USD 55 billion by the year 2020.
So how does this affect your life? Are your organizational goals aligning towards increased production or improved security to safeguard the IP that took long to develop? Are you worried about your competitor who is perhaps exploring Industries 5.0 while you are still implementing and far from the benefits of Industries 4.0?
Will your business know-how coupled with technology, disrupt the ever changing industry? Or will the industry continue to be giant only in the Generics
market? These are the challenges and questions a business leader from this industry is busy pondering about and staying in silos will not take the industry forward.
Keeping this in mind Exito Media Concepts
is back with the fifth edition of the Pharma
Innovation and Technology Summit
The premium conference that hosts only 80 key decision makers from the leading pharma corporate in India takes place on 8th December in Mumbai.
The event gives the Information and technology heads a chance to network among their peers while gaining latest information, first hand from the industry leaders.
The conference will be centered around key topics like Automation and integrating IOT, latest advances in clinical trial management system, laboratory information management system and SMAC (Social, Mobile, Analytics and Cloud).
Key decision makers like VP and CIO from Wanbury, Group CEP of Batra's health care, VP regulatory affairs from Unimark ltd have been a part of this premium conference. The conference acts as a knowledge sharing platform where attendees get to learn through a series of informative keynotes and presentations and interactive panel discussions.
Open only for the decision makers the conference will see an attendance of CIOs, CTOs, Head of Security, CEOs and Policy makers from the top companies in the pharma and life science industry.
"We have come a long way from the first edition of this event. Our attendees have repeatedly recommended this conference because of the quality content and business opportunities we provide here.
The unique format that gives ample networking opportunities is a hit among the delegates and solution providers alike," says Exito's MD Rishikesh Shetty. Join us in Mumbai for the year's last gathering of management suite in the pharma and life sciences sector. (ANI